U.K. drug regulators are examining whether Ozempic and other weight-loss drugs raise the risk of suicidal thinking and thoughts of self harm
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.
Study explores potential risk of suicidal thinking, thoughts of self-harmDiabetes drugs could become an effective way to treat behavioral issues and addiction. WSJ’s Daniela Hernandez breaks down the science on how they work and how they could change psychiatry forever. Photo illustration: Elizabeth Smelov
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
The science and side effects of the drugs Ozempic and WegovyFrom how well they work to side effects such as hair loss, here’s the skinny on new weight loss injections that work by blocking a hormone that normally reduces appetite
続きを読む »
Popular Weight Loss Drugs Like Ozempic Can Cause Stomach Paralysis: ReportAccording to CNN, doctors noted an uptick in severe cases of gastroparesis, also known as stomach paralysis, since weight loss drugs Ozempic and Wegovy have attained notoriety (thanks in part to celebrity and influencer testimonials).
続きを読む »
UK investigates weight loss, diabetes drugs like Wegovy and Ozempic for suicide risksThe probe into potentially life-threatening side effects comes as the drugs skyrocket in popularity in the U.S. and draw heightened investor interest.
続きを読む »
Dr. Terry Dubrow blasts Ozempic shaming: ‘Stop making people feel bad’Because there’s so much negativity surrounding the drug, people may feel shamed into not talking about its side effects.
続きを読む »
Ozempic Users Report Stomach Paralysis from Weight Loss Drug: 'So Much Hell'An investigation found people reporting distressing possible side effects from the popular injectable medication.
続きを読む »
Exclusive: UK probes Novo's Ozempic, weight-loss drug Saxenda over suicidal, self-harming thoughtsBritain is reviewing a class of drugs used in a diabetes medicine and a weight-loss treatment sold by Novo Nordisk after some patients reported suicidal or self-harming thoughts, two weeks after similar action by the European Union.
続きを読む »